Funding for this research was provided by:
National Institutes of Health (K23 AR069688)
National Institutes of Health (L30 AR066953, R01 AR049880, R01 AR059073, K24 AR052403, K24 AR 066109, UM1 CA176726, R01 CA049449, R01 CA067262, P30 AR070253, P30 AR072577)
Rheumatology Research Foundation (K Supplement Award)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R03 AR075886)
Received: 20 May 2019
Accepted: 17 October 2019
First Online: 21 November 2019
Ethics approval and consent to participate
: All components of this study were approved by the Partners HealthCare Institutional Review Board. Informed consent to participate was obtained from all individual participants.
: No individual-level data are contained in this report.
: Dr. Sokolove is currently an employee of GlaxoSmithKline.